Wed, Jun 19, 2024
43.2 C
Dubai
Home Tags Pfizer

Tag: Pfizer

COVID-19 vaccine: Stay updated on the most recent developments

When is a solution to COVID-19 actually going to become widely available? This month, the answer to this question will finally be found as...

Need 2-month data to approve COVID-19 vaccine: US FDA

The US Food and Drug Administration (FDA) has finally made its process behind COVID-19 vaccine approval public answering some very critical questions on why...

COVID-19: Pfizer hopeful of vaccine success in trials

Pfizer, the US based drugmaker, is betting that its coronavirus vaccine candidate will show strong signs of success early in its clinical trial, says...

Pfizer & BioNTech expand Phase 3 trials to diverse participants

The US-based pharmaceutical giants Pfizer and German biotech firm BioNTech have decided to expand their Phase 3 COVID-19 vaccine candidate trials to 44,000 participants. The...

Our COVID-19 vaccine is “near-perfect”: BioNTech CEO

Amid slightly concerning news of AstraZeneca-Oxford vaccine trails being halted due to complications with one of the COVID-19 vaccine volunteers in the UK, CEO...

Moderna COVID-19 vaccine hard to store and administer to masses

Executives from Moderna and Pfizer, two leading mRNA based vaccine developer have separately intimated Centers for Disease Control and Prevention’s Advisory Committee on Immunization...

COVID Vaccine; Get most credible information on the virus cure

As part of its extensive coverage on the coronavirus vaccine development progress, GCC Business News is providing regular updates which are derived from the...

Americans to get free COVID vaccines; Deal with Pfizer and BioNTech...

The United States government has reached into an agreement worth $1.95 billion with US-based vaccine maker Pfizer and German biotechnology company BioNTech to produce...
IDC Saudi Arabia CIO Summit 2024

IDC Saudi Arabia CIO Summit 2024

Emerging Tech Summit

Emerging Tech Summit 2024

Global AI Show

Global AI Show 2024

LATEST ARRIVALS

MORE FROM THE TOPIC